US FDA grants breakthrough device designation to Roche's companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for ...
Roche announced that the US Food and Drug Administration (FDA) granted Breakthrough Device Designation for the VENTANA TROP2 (EPR20043) RxDx Device. This is the first Breakthrough Device Designation to be granted for a computational pathology companion …